J. Findlay Walker

1.0k total citations
22 papers, 820 citations indexed

About

J. Findlay Walker is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, J. Findlay Walker has authored 22 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in J. Findlay Walker's work include Lipoproteins and Cardiovascular Health (7 papers), Blood Pressure and Hypertension Studies (7 papers) and Plant biochemistry and biosynthesis (3 papers). J. Findlay Walker is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Blood Pressure and Hypertension Studies (7 papers) and Plant biochemistry and biosynthesis (3 papers). J. Findlay Walker collaborates with scholars based in United States, Belgium and New Zealand. J. Findlay Walker's co-authors include Tomás S. Bocanegra, Suzanne Oparil, Richard O. Davies, Federico Moncloa, HJ Gomez, Deborah R. Shapiro, John D. Irvin, Norman Sharpe, Giovanni de Simone and Jonathan N. Bella and has published in prestigious journals such as Circulation, The American Journal of Medicine and European Heart Journal.

In The Last Decade

J. Findlay Walker

22 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Findlay Walker United States 14 431 223 222 138 97 22 820
Brunner Hr Switzerland 13 761 1.8× 97 0.4× 363 1.6× 269 1.9× 107 1.1× 75 1.2k
Jin‐Jer Chen Taiwan 19 504 1.2× 175 0.8× 274 1.2× 310 2.2× 60 0.6× 55 1.4k
Paulette A. Lyle United States 19 563 1.3× 76 0.3× 367 1.7× 256 1.9× 70 0.7× 42 1.3k
Mojca Stegnar Slovenia 20 284 0.7× 176 0.8× 151 0.7× 226 1.6× 47 0.5× 75 1.3k
Kenneth L. Duchin United States 17 383 0.9× 60 0.3× 113 0.5× 226 1.6× 63 0.6× 43 1.0k
Lata Kler United Kingdom 11 206 0.5× 95 0.4× 207 0.9× 186 1.3× 44 0.5× 15 571
David A Willard United States 11 190 0.4× 86 0.4× 72 0.3× 176 1.3× 82 0.8× 14 569
Neville F. Ford United States 17 549 1.3× 247 1.1× 227 1.0× 71 0.5× 25 0.3× 32 954
K. Peter Öhman Sweden 18 622 1.4× 103 0.5× 399 1.8× 293 2.1× 85 0.9× 53 1.1k
Kazuo Ichihara Japan 20 349 0.8× 460 2.1× 147 0.7× 381 2.8× 88 0.9× 84 1.2k

Countries citing papers authored by J. Findlay Walker

Since Specialization
Citations

This map shows the geographic impact of J. Findlay Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Findlay Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Findlay Walker more than expected).

Fields of papers citing papers by J. Findlay Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Findlay Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Findlay Walker. The network helps show where J. Findlay Walker may publish in the future.

Co-authorship network of co-authors of J. Findlay Walker

This figure shows the co-authorship network connecting the top 25 collaborators of J. Findlay Walker. A scholar is included among the top collaborators of J. Findlay Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Findlay Walker. J. Findlay Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giles, Thomas D., et al.. (2007). Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension. Journal of Clinical Hypertension. 9(3). 187–195. 68 indexed citations
3.
Walker, J. Findlay. (1992). Worldwide experience with simvastatin/lovastatin. European Heart Journal. 13(suppl B). 21–22. 8 indexed citations
4.
Boccuzzi, Stephen J., et al.. (1991). Long-term safety and efficacy profile of simvastatin. The American Journal of Cardiology. 68(11). 1127–1131. 87 indexed citations
5.
Walker, J. Findlay & Deborah R. Shapiro. (1990). Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia. The American Journal of Cardiology. 65(12). 19–22. 10 indexed citations
6.
Walker, J. Findlay, et al.. (1990). Efficacy and Tolerability of Simvastatin (Epistatin) in the Elderly. Clinical Drug Investigation. 2(S2). 53–56. 4 indexed citations
7.
Walker, J. Findlay. (1989). Simvastatin: The clinical profile. The American Journal of Medicine. 87(4A). S44–S46. 60 indexed citations
8.
Tikkanen, Matti J., et al.. (1989). Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. The American Journal of Medicine. 87(4A). S47–S53. 43 indexed citations
9.
Rucinska, Ewa, Roy S. Small, Donald L. Snyder, et al.. (1989). Tolerability of Long Term Therapy with Enalapril Maleate in Patients Resistant to Other Therapies and Intolerant to Captopril. Drug Safety. 4(2). 144–152. 12 indexed citations
10.
Walker, J. Findlay. (1988). HMG CoA Reductase Inhibitors. Drugs. 36(Supplement 3). 83–86. 26 indexed citations
11.
Walker, J. Findlay & Jonathan A. Tobert. (1987). The clinical efficacy and safety of lovastatin and MK-733--an overview. European Heart Journal. 8(suppl E). 93–96. 22 indexed citations
12.
Шапиро, Д. А., et al.. (1987). Enalapril and Hydrochlorothiazide as Antihypertensive Agents in the Elderly. Journal of Cardiovascular Pharmacology. 10. 160–162. 10 indexed citations
13.
Walker, J. Findlay, et al.. (1987). A Comparison of Enalapril and Metoprolol as Initial Therapy for Mild to Moderate Hypertension. The Journal of Clinical Pharmacology. 27(7). 461–467. 9 indexed citations
14.
Miller, Kenneth G., et al.. (1987). Enalapril. Journal of Cardiovascular Pharmacology. 10. 154–156. 7 indexed citations
15.
Gómez, Héctor W., Vincent J. Cirillo, Richard O. Davies, James A. Bolognese, & J. Findlay Walker. (1986). Enalapril in congestive heart failure: acute and chronic invasive hemodynamic evaluation. International Journal of Cardiology. 11(1). 37–48. 16 indexed citations
16.
Moncloa, Federico, et al.. (1985). Enalapril in Hypertension and Congestive Heart Failure. Drugs. 30(Supplement 1). 82–89. 25 indexed citations
17.
Davies, Richard O., et al.. (1984). Enalapril Worldwide Experience. The American Journal of Medicine. 77(2). 23–35. 84 indexed citations
18.
Smith, Warren, et al.. (1984). Tolerance and safety of enalapril.. British Journal of Clinical Pharmacology. 18(S2). 249S–253S, 255S. 15 indexed citations
19.
Walker, J. Findlay, et al.. (1984). The efficacy and safety of enalapril in moderate to severe essential hypertension.. PubMed. 2(2). S107–11. 6 indexed citations
20.
Gomez, HJ, et al.. (1984). An overview of the clinical pharmacology of enalapril.. British Journal of Clinical Pharmacology. 18(S2). 215S–229S. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026